Non-Immune Cells |
|
|
Hepatocyte |
Induce ISGs, IFN (type III>I) via RIG-I or MDA5/MAVS pathway or TLR3 upon recognition of HCV PAMPs in infected cells.
Induce ISGs via IFN-Jak-STAT signaling.
|
Core and NS5A: Inhibit Jak-STAT signaling pathway.
NS3/4A: Disrupt RLHs and TLR3 signaling by cleaving MAVS.
NS4B: Interfere RIG-I signaling through STING inhibition.
|
Cholangiocyte |
May play a role in inflammatory cytokines production by recognizing HCV PAMPs via TLRs. |
|
HSC |
Produce antiviral cytokines by recognizing HCV via TLRs.
The source of retinol (vitamin A), which support antiviral ISGs production in hepatocytes.
|
|
LSEC |
Recognize HCV via PRRs (both RIG-I like helicases and TLRs).
Likely serves as antigen presenting cell.
Production of type I/III IFN and antiviral exosomes.
|
Use L-/DC-SIGN to transport virion to space of Disse.
BMP4 enhances HCV replication in hepatocytes.
Support expression of LDL-R in hepatocytes(co-receptor of HCV entry)
|
Innate Immune Cells |
|
|
Kupffer cell /Macrophage
|
-
Produce inflammatory cytokines by recognizing HCV PAMPs via TLRs.
-
-
HCV core and NS3 proteins by TLR2/TLR1 and TLR2/TLR6 heterodimer complex.
-
-
Phagocytosed HCV virion stimulates TLR7/8, result in NLRP3 dependent inflammasomes.
Possibly plays a role in hepatic inflammation by phagocytosis of apoptotic body, DAMPs, or exosomes from infected cells.
|
TNF-α upregulate OCLN and CD81 in hepatocytes.
Core and NS5A: Block TLR signaling pathways.
|
DC |
-
Myeloid DC1 (BDCA-1):
-
-
Produce TNF-α and IL-10 via TLR2 activation by core or NS3 protein.
-
-
Produce of IL-6,IL-1β, IL-12 and type I IFN via TLR3.
-
Myeloid DC2 (BDCA-3)
-
Plasmacytoid DC (BDCA-2)
-
-
Produce type I IFN via TLR3, 7, 8, 9 upon phagocytosis of HCV particle or by engulfing exosomes containing PAMPs.
|
Core and E1: Prohibit the maturation of DC.
E2 binds to BDCA-1, CLRs, DCIR and inhibit production of type I IFN.
|
NK cell |
CD56brightCD3− cells
|
E2 inhibit the activation of NKs via binding to CD81. |